IBIO, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
IBIO, INC. (IBIO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $688.00 thousand as of 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-28
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $688.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $683.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $679.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $674.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $688.00K 10-K · filed 2026-08-28 |
| 2026-03-31 | $683.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $679.00K 10-Q · filed 2026-02-10 |
| 2025-09-30 | $674.00K 10-Q/A · filed 2025-11-17 |
| 2025-06-30 | $669.00K 10-K · filed 2025-09-05 |
| 2025-03-31 | $664.00K 10-Q · filed 2025-05-02 |
| 2024-12-31 | $658.00K 10-Q · filed 2025-02-10 |
| 2024-09-30 | $653.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $648.00K 10-K/A · filed 2024-09-24 |
| 2024-03-31 | $424.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $412.00K 10-Q · filed 2024-02-09 |
| 2023-09-30 | $400.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $389.00K 10-K · filed 2023-09-27 |
| 2023-03-31 | $377.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $315.00K 10-Q/A · filed 2023-05-19 |
| 2022-09-30 | $183.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $101.00K 10-K · filed 2022-10-11 |
| 2022-03-31 | $10.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $160.00K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $147.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |